| Structure of the complex of human programmed death 1, PD-1, and its ligand PD-L1 KM Zak, R Kitel, S Przetocka, P Golik, K Guzik, B Musielak, A Dömling, ... Structure 23 (12), 2341-2348, 2015 | 505 | 2015 |
| Exfoliative Toxins of Staphylococcus aureus M Bukowski, B Wladyka, G Dubin Toxins 2 (5), 1148-1165, 2010 | 366 | 2010 |
| Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1) KM Zak, P Grudnik, K Guzik, BJ Zieba, B Musielak, A Dömling, G Dubin, ... Oncotarget 7 (21), 30323, 2016 | 323 | 2016 |
| Structural biology of the immune checkpoint receptor PD-1 and its ligands PD-L1/PD-L2 KM Zak, P Grudnik, K Magiera, A Dömling, G Dubin, TA Holak Structure 25 (8), 1163-1174, 2017 | 319 | 2017 |
| Small-molecule inhibitors of the programmed cell death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction via transiently induced protein states and dimerization of PD-L1 K Guzik, KM Zak, P Grudnik, K Magiera, B Musielak, R Torner, L Skalniak, ... Journal of Medicinal Chemistry 60 (13), 5857-5867, 2017 | 286 | 2017 |
| Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells L Skalniak, KM Zak, K Guzik, K Magiera, B Musielak, M Pachota, ... Oncotarget 8 (42), 72167, 2017 | 254 | 2017 |
| Extracellular proteases of Staphylococcus spp. G Dubin Walter de Gruyter 383 (7-8), 1075-1086, 2002 | 213 | 2002 |
| Proteinaceous cysteine protease inhibitors G Dubin Cellular and molecular life sciences 62, 653-669, 2005 | 195 | 2005 |
| Bioactive macrocyclic inhibitors of the PD‐1/PD‐L1 immune checkpoint K Magiera‐Mularz, L Skalniak, KM Zak, B Musielak, E Rudzinska‐Szostak, ... Angewandte Chemie International Edition 56 (44), 13732-13735, 2017 | 160 | 2017 |
| Staphylococcal proteases aid in evasion of the human complement system M Jusko, J Potempa, T Kantyka, E Bielecka, HK Miller, M Kalinska, ... Journal of innate immunity 6 (1), 31-46, 2014 | 131 | 2014 |
| High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx A Czarna, GM Popowicz, A Pecak, S Wolf, G Dubin, TA Holak Cell cycle 8 (8), 1176-1184, 2009 | 125 | 2009 |
| Molecular cloning and biochemical characterisation of proteases from Staphylococcus epidermidis G Dubin, D Chmiel, P Mak, M Rakwalska, M Rzychon, A Dubin Walter de Gruyter 382 (11), 1575-1582, 2001 | 113 | 2001 |
| Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015) T Zarganes-Tzitzikas, M Konstantinidou, Y Gao, D Krzemien, K Zak, ... Expert opinion on therapeutic patents 26 (9), 973-977, 2016 | 100 | 2016 |
| Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin P Kulig, BA Zabel, G Dubin, SJ Allen, T Ohyama, J Potempa, TM Handel, ... The Journal of Immunology 178 (6), 3713-3720, 2007 | 88 | 2007 |
| Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73 M Zdzalik, K Pustelny, S Kedracka-Krok, K Huben, A Pecak, B Wladyka, ... Cell cycle 9 (22), 4584-4591, 2010 | 84 | 2010 |
| Functional and structural characterization of Spl proteases from Staphylococcus aureus GM Popowicz, G Dubin, J Stec-Niemczyk, A Czarna, A Dubin, J Potempa, ... Journal of molecular biology 358 (1), 270-279, 2006 | 80 | 2006 |
| Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011–present) K Zak, A Pecak, B Rys, B Wladyka, A Doemling, L Weber, TA Holak, ... Expert Opinion on Therapeutic Patents 23 (4), 425-448, 2013 | 79 | 2013 |
| A novel matrix metalloprotease-like enzyme (karilysin) of the periodontal pathogen Tannerella forsythia ATCC 43037 AY Karim, M Kulczycka, T Kantyka, G Dubin, A Jabaiah, PS Daugherty, ... Walter de Gruyter 391 (1), 105-117, 2010 | 79 | 2010 |
| Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies B Pucelik, R Paczyński, G Dubin, MM Pereira, LG Arnaut, JM Dąbrowski PLoS One 12 (10), e0185984, 2017 | 72 | 2017 |
| Sensitization of TiO2 by halogenated porphyrin derivatives for visible light biomedical and environmental photocatalysis A Sułek, B Pucelik, J Kuncewicz, G Dubin, JM Dąbrowski Catalysis Today 335, 538-549, 2019 | 71 | 2019 |
Katarzyna Magiera-MularzVerified email at uj.edu.pl
